中国骨髓腔内输液通路临床应用专家共识

2019-07-30 中国医药教育协会 中国急救医学.2019.39(7):620-624.

骨髓腔内输液是一种能够快速、安全、有效的建立血管通道的方法。2014年《新英格兰医学杂志》全面介绍了骨髓腔内输液,还制作了骨髓腔内输液操作的视频,建议医生合理、正确、积极地使用这一技术。我国医护人员对骨髓腔内输液通路的了解、掌握及应用与国际相比目前仍存在很大差距,2016年北京地区的一项调查结果。21显示,医护人员对骨髓腔内输液的知晓率仅为32.6%,了解骨髓腔内输液适应证和操作流程者分别占4.0

中文标题:

中国骨髓腔内输液通路临床应用专家共识

发布机构:

中国医药教育协会

发布日期:

2019-07-30

简要介绍:

骨髓腔内输液是一种能够快速、安全、有效的建立血管通道的方法。2014年《新英格兰医学杂志》全面介绍了骨髓腔内输液,还制作了骨髓腔内输液操作的视频,建议医生合理、正确、积极地使用这一技术。我国医护人员对骨髓腔内输液通路的了解、掌握及应用与国际相比目前仍存在很大差距,2016年北京地区的一项调查结果。21显示,医护人员对骨髓腔内输液的知晓率仅为32.6%,了解骨髓腔内输液适应证和操作流程者分别占4.0%和3.8%。为推动和提高广大医护人员对骨髓腔内输液通路的临床合理应用,中国医药教育协会急诊医学专业委员会、中华医学会北京心血管病学分会青年委员会等共同组织相关领域专家编制了该共识,旨在规范并提升临床医护人员对骨髓腔内输液通路的实践能力,为进一步开展临床实践和研究提供指导意见。

 

拓展指南:骨髓相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国骨髓腔内输液通路临床应用专家共识)] GetToolGuiderByIdResponse(projectId=1, id=58bb21c001e81a19, title=中国骨髓腔内输液通路临床应用专家共识, enTitle=, guiderFrom=中国急救医学.2019.39(7):620-624., authorId=null, author=, summary=骨髓腔内输液是一种能够快速、安全、有效的建立血管通道的方法。2014年《新英格兰医学杂志》全面介绍了骨髓腔内输液,还制作了骨髓腔内输液操作的视频,建议医生合理、正确、积极地使用这一技术。我国医护人员对骨髓腔内输液通路的了解、掌握及应用与国际相比目前仍存在很大差距,2016年北京地区的一项调查结果。21显示,医护人员对骨髓腔内输液的知晓率仅为32.6%,了解骨髓腔内输液适应证和操作流程者分别占4.0, cover=, journalId=null, articlesId=null, associationId=1778, associationName=中国医药教育协会, associationIntro=, copyright=0, guiderPublishedTime=Tue Jul 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>骨髓腔内输液是一种能够快速、安全、有效的建立血管通道的方法。2014年《新英格兰医学杂志》全面介绍了骨髓腔内输液,还制作了骨髓腔内输液操作的视频,建议医生合理、正确、积极地使用这一技术。我国医护人员对骨髓腔内输液通路的了解、掌握及应用与国际相比目前仍存在很大差距,2016年北京地区的一项调查结果。21显示,医护人员对骨髓腔内输液的知晓率仅为32.6%,了解骨髓腔内输液适应证和操作流程者分别占4.0%和3.8%。为推动和提高广大医护人员对骨髓腔内输液通路的临床合理应用,中国医药教育协会急诊医学专业委员会、中华医学会北京心血管病学分会青年委员会等共同组织相关领域专家编制了该共识,旨在规范并提升临床医护人员对骨髓腔内输液通路的实践能力,为进一步开展临床实践和研究提供指导意见。 </P> <P> </P>拓展指南:<strong>与<font color=red>骨髓</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=5fd871c001e67972" title="2019 ASCO与CCO联合临床实践指南:多发性骨髓瘤的治疗" target=_blank>2019 ASCO与CCO联合临床实践指南:多发性骨髓瘤的治疗</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b89da1c001e5297d" title="NCCN临床实践指南:多发性骨髓瘤(2019.V3)" target=_blank>NCCN临床实践指南:多发性骨髓瘤(2019.V3)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=7e8631c001ea430e" title="2019 专家共识声明:多发性骨髓瘤首次复发的正确评估" target=_blank>2019 专家共识声明:多发性骨髓瘤首次复发的正确评估</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=01adf1c001e306b2" title="多发性骨髓瘤遗传学检测专家共识" target=_blank>多发性骨髓瘤遗传学检测专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=a6ad81c001e29207" title="2018 JSH实践指南:血液恶性肿瘤—骨髓瘤:多发性骨髓瘤相关疾病" target=_blank>2018 JSH实践指南:血液恶性肿瘤—骨髓瘤:多发性骨髓瘤相关疾病</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E9%AA%A8%E9%AB%93" target=_blank>有关骨髓更多指南</a></ul>, tagList=[TagDto(tagId=93584, tagName=骨髓腔内输液通路), TagDto(tagId=611, tagName=临床应用)], categoryList=[CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7758, appHits=210, showAppHits=0, pcHits=6110, showPcHits=2199, likes=58, shares=9, comments=8, approvalStatus=1, publishedTime=Tue Aug 20 00:12:10 CST 2019, publishedTimeString=2019-07-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Aug 20 00:12:10 CST 2019, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 21:07:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国骨髓腔内输液通路临床应用专家共识)])
中国骨髓腔内输液通路临床应用专家共识
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2112594, encodeId=ba3a211259429, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:24 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112593, encodeId=2fb5211259366, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:08 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112597, encodeId=e707211259e28, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:55:45 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112592, encodeId=eeb5211259277, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:03 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1068781, encodeId=3c821068e816e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ed5693270, createdName=ms2000000930126127, createdTime=Tue Nov 09 22:33:10 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2023-02-01 一己怀 来自山东省

    中国骨髓腔内输液通路临床应用专家共识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2112594, encodeId=ba3a211259429, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:24 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112593, encodeId=2fb5211259366, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:08 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112597, encodeId=e707211259e28, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:55:45 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112592, encodeId=eeb5211259277, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:03 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1068781, encodeId=3c821068e816e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ed5693270, createdName=ms2000000930126127, createdTime=Tue Nov 09 22:33:10 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2023-02-01 一己怀 来自山东省

    中国骨髓腔内输液通路临床应用专家共识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2112594, encodeId=ba3a211259429, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:24 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112593, encodeId=2fb5211259366, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:08 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112597, encodeId=e707211259e28, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:55:45 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112592, encodeId=eeb5211259277, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:03 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1068781, encodeId=3c821068e816e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ed5693270, createdName=ms2000000930126127, createdTime=Tue Nov 09 22:33:10 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2023-02-01 一己怀 来自山东省

    中国骨髓腔内输液通路临床应用专家共识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2112594, encodeId=ba3a211259429, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:24 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112593, encodeId=2fb5211259366, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:08 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112597, encodeId=e707211259e28, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:55:45 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112592, encodeId=eeb5211259277, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:03 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1068781, encodeId=3c821068e816e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ed5693270, createdName=ms2000000930126127, createdTime=Tue Nov 09 22:33:10 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2023-02-01 一己怀 来自山东省

    非常实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2112594, encodeId=ba3a211259429, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:24 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112593, encodeId=2fb5211259366, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:08 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112597, encodeId=e707211259e28, content=中国骨髓腔内输液通路临床应用专家共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:55:45 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2112592, encodeId=eeb5211259277, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Wed Feb 01 16:52:03 CST 2023, time=2023-02-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1068781, encodeId=3c821068e816e, content=非常实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56ed5693270, createdName=ms2000000930126127, createdTime=Tue Nov 09 22:33:10 CST 2021, time=2021-11-09, status=1, ipAttribution=)]
    2021-11-09 ms2000000930126127

    非常实用

    0